Merck’s Kenneth Frazier to Retire as CEO Effective June 30
Merck’s outspoken chairman and CEO, Ken Frazier, is retiring after almost 30 years at the drugmaker, the company announced Thursday...
Related Articles
- Why Should We Care About Corporate Interlocks? also categorized in BoardNews
- The Other Duty of Corporate Governance also categorized in BoardNews
- Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews
- Warren Buffett to Retire from Kraft Heinz Board, Aiming to Decrease Travel Commitments also mentions retire
- Germany's Corporate Governance Problem also categorized in BoardNews
- 20 Taiwan Businesspeople To Watch -- James Kuo, Austin Liu and Andy Lu also categorized in BoardNews
- Duke CEO: Board Lost Confidence in Progress Chief also published in CNBC.com
- Have the Swiss Gone Cuckoo? also categorized in BoardNews
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
- Carl Icahn: Netflix Poison-Pill Move 'Reprehensible' also published in CNBC.com
Login to comment.